| Publicly Funded Medicine |
Website Links For Medicine |
Information AboutPublicly Funded Medicine |
|
Publicly funded medicine, also called "socialized healthcare" or "universal healthcare", is a Healthcare System that is financed entirely or in majority part by citizens' tax payments instead of through private payments made to insurance companies or directly to health care providers (healthcare Premium s, Copayment s or Deductibles ). VARIETIES OF PUBLIC SYSTEMS Most Developed Countries currently have publicly funded health systems that cover the great majority of the population. The notable exception is the United States . For some examples, see the United Kingdom's National Health Service (NHS), or the Medicare systems In Canada and In Australia . The role of the government in healthcare provision is a source of continued and sharp debate. Even among these countries, different approaches exist to the funding and provision of medical services. Systems may be funded from general government revenues (as in government pays the bulk of the fees for dental and eye care, while the Australian government covers neither. Publicly funded medicine may be administered and provided by the Government , as in the United Kingdom ; in some systems, though, medicine is publicly funded but most health providers are private entities, as in Canada. The organization providing public health insurance is not necessarily a public administration, and its budget may be isolated from the main state budget. Some systems do not provide universal healthcare, or restrict coverage to public health facilities. Some countries, such as Germany , have multiple public insurance organizations linked by a common legal framework. Every health care system faces funding problems. Innovations in heath care can be very expensive. Population Aging generally implies more health care, at a time when the taxed working population decreases. TWO-TIER HEALTH CARE See Also: Two-tier health care Almost every country that has a publicly funded health care system also has a parallel private system, generally catering to private insurance holders. While one goal of public systems is to provide equal service to all, this Egalitarianism is often partial. Every nation either has parallel private providers or its citizens are free to travel to a nation that does, so there is effectively a Two-tier Healthcare system that reduces the Equality of service. Private hospitals often get newer and better equipment and facilities, and since private providers are typically better paid, some medical professionals motivated by remunerative concerns migrate to the private sector. From the inception of the NHS model ( 1948 ), public hospitals in the United Kingdom have included "amenity beds" which would typically be siderooms fitted more comfortably, and private wards in some hospitals where for a fee more amenities are provided. These are predominantly used for surgical treatment, and operations are generally carried out in the same operating theatres as NHS work and by the same personnel. These amenity beds do not exist in other socialized healthcare systems, such as the Spanish one. From time to time, the NHS pays for private hospitals (''arranged hospitals'') to take on surgical cases for which NHS facilities do not have sufficient capacity. This work is usually, but not always, done by the same doctors in private hospitals. In some cases, doctors are well paid in both systems, and prestige is more important than remuneration. In the United Kingdom, private medicine is generally seen as less prestigious than public medicine. British usage of private healthcare is generally for prompt, convenient treatment, rather than better clinical care. PUBLIC SYSTEMS AROUND THE WORLD
CLAIMS MADE FOR PUBLICLY-FUNDED MEDICINE Claimed advantages are
According to a 2000 study of the and per capita, and enjoy superior population-based health care outcomes. OPPOSITION TO PUBLICLY FUNDED MEDICINE Opponents claim publicly funded medicine has several disadvantages:
Doctors' salaries tend to be lower in public systems; for example those in the United States are twice those in Canada. Opponents claim that higher salaries constitute an incentive to enter the profession and attract more qualified individuals who would otherwise choose a different profession. Another possible criticism cites the fairness of paying for people's poor individual decisions (obesity, smoking, drinking, drugging, etc.) as they relate to health care costs. It is argued that these costs should be incurred solely by those making those poor decisions. In 2006, Sylvia Lott, aged 72, made headlines in the UK after waiting thirteen years for a hip replacement surgery from the Swansea NHS Trust, South Wales' publicly-funded health insurer. Critics cite these kind of bureaucratic mistakes as inherant in a system where bureaucrats do not have market driven incentives to ensure that patients receive high-quality treatments, or any at all. ROLE OF THE FREE MARKET Neoliberal economists argue that no nation currently operates a truly free market in the delivery of health care. Some of them also argue that the free market is better able to allocate discretionary spending where consumers value it the most. There is variation amongst individuals about how much they value peace of mind and a lower risk of death. For example, a public-funded system, based on cost efficiency, might limit access to a Pap Smear only once every five years if the patient was not positive for the Human Papilloma Virus . In a private system, a consumer can choose to be screened more often, and enjoy the luxury of greater peace of mind and reduced risk, if they value this more than other luxury items. Such "luxury" discretionary spending might be moved to non-medical luxury goods and should not be viewed as available to fund a public system as is assumed in some analyses. Aspects of the United States health system See Also: Health care in the United States Whether publicly funded healthcare can adequately deliver health care more cost effectively than the Free Market is a matter of much debate. Of all developed nations, the healthcare system of the United States has the highest degree of privatization. Consequently, it is frequently cited by those favoring or opposing universal healthcare. The cost and quality of care in the United States are frequently the two major issues of discussion. Although the United States is below the average for developed countries in health measures such as survival rates, relevant statistics include people not covered by any insurance and those covered by the system get what is arguably the best health care in the world. Access to advanced medical treatments and technologies is greater than in most other developed nations and waiting times are substantially shorter for treatment by specialists {Link without Title} . Also many foreign citizens visit the U.S. to obtain treatments unavailable or available only with long waiting lists in their home countries. The United States does spend more on health care, as an absolute dollar amount and per capita, than any other nation. It also spends a greater fraction of its national budget on health care than Canada, Germany, France, or Japan. In 2001 the United States spent $4,887 USD per person on health care, more than double the rate of any other G7 country except Japan, which spent $2,627 per capita annually. Risk factors specific to the U.S. population, such as a relatively high prevalence of obesity, may partially explain increased health care spending; however, many other industrialized nations do share these problems to some extent. Although the U.S. Medicare coverage of prescription drugs is scheduled to begin in 2006 , most Patent ed Prescription Drug s are significantly more costly in the United States than in most other countries. Factors involved are the absence of U. S. government Price Control s, enforcement of Intellectual Property Rights limiting the availability of Generic Drug s until after patent expiration, and the monopoly purchasing power seen in national single-payer systems. Many U.S. citizens obtain their medications, directly or indirectly, from foreign sources, to take advantage of lower prices. The United States system does have substantial public components. Of every dollar spent on health care in the United States, 44 cents comes from some level of government. The elderly are covered by Medicare, the poor (those with assets of less than $2,000) are covered by Medicaid, merchant seamen are covered by the Public Health System, and retired railway workers and military veterans are also covered by the government. Government also affects private sector medicine through licensing and regulatory barriers to entry into health professions. Most experts believe that the U.S. system is best described as exhibiting greater Inequality than others, with covered people receiving a very high quality of care and the uninsured and underinsured receiving a lower standard of care. It is not clear that the lower standard of care received by the uninsured and underinsured in the United States is actually lower than that of other nations that provide complete publicly funded health care. Facilities, such as emergency rooms, hospitals, and urgent care facilities are often required to treat everyone by law. Cost-cutting in the private sector Some health economists assert that traditional private plans are not very good at limiting spending to cost-effective procedures and schedules, and that consumers exploiting this would view the transition to a public system as a reduction in their compensation or benefits. Other health economists believe that with the growth of Health Maintenance Organization s and other cost-cutting entities, private plans now limit spend, with consequences for paperwork and some needed treatments. A number of high-profile instances of Medicaid fraud have been uncovered among health care providers and medical device suppliers. Market failure issues Various healthcare analysts have asserted that Market Failure occurs in healthcare markets but some have suggested that it is result of too much government involvement rather than too little [http://www.massey.ac.nz/~kbirks/hecon/pha93.htm [http://www.fff.org/freedom/fd0409g.asp]. The consumers of health care often lack basic information compared to the medical professionals they buy it from, and fully informed choices (particularly in emergencies) are often not plausible. Meanwhile, health insurance companies and care providers also suffer from Information Asymmetry , as patients are almost always more aware of their particular family histories and risky behaviors than the firms are. Price theory dictates that the risk cost associated with this lack of information gets passed on to consumers. Demand is likely to be Inelastic . The medical profession potentially may set rates that are well above ideal market value, and they are controlled by licensing requirements, with some degree of Monopoly or Oligopoly control over prices. Monopolies are made more likely by the variety of specialists and the importance of geographic proximity. Private insurance has been perhaps the only stabilizing force as they pay a contractually fixed cost for a given procedure. With no more than one or two heart specialists or brain surgeons to choose from, competition for patients between such experts is limited so contractually pre-arranged pricing helps reduce supply-limited pricing. Preventive medicine issues There is much conflicting information about the role of preventive medicine in controlling medical costs and the improving the health of citizens. Advocates of publicly funded medicine claim that preventive care saves money and prolongs life but opponents assert that it does neither [http://www.ncpa.org/ba/ba188.html [http://www.debate-central.org/topics/2002/book2.pdf]. DIFFICULTIES OF ANALYSIS Cost-benefit analysis of healthcare is extremely difficult to do accurately. For instance, prevention of smoking or obesity is presented as having the potential to save the costs of treating illnesses arising from those choices. Yet, if those illnesses are fatal or life shortening, they may reduce the eventual cost to the system of treating that person through the rest of their life, possibly dying of an illness every bit as expensive to treat as the ones they avoided by a healthy lifestyle. This has to be balanced against the loss of taxation or insurance revenue that might come should a person have a longer productive (i.e. working and tax or insurance-paying) life. The cost-benefit analysis will be very different depending on whether you adopt a whole-life accounting, or consider each month as debits and credits on an insurance system. In a system financed by taxation, the greatest cost benefit comes from preserving the working life of those who are likely to pay the most tax in future, i.e. the young and rich. Few politicians would dare to present the big picture of costs in this way, because they would be condemned as callous. Nevertheless, behind the scenes, a responsible government must be performing cost analysis in order to balance its budget; it is not likely, however, to take the most purely cost effective route. It may choose to provide the "best" health care according to some other model, but the cost of this still must be estimated and funded, and there is no uncontroversial definition of "best". In producing a definition of quality of healthcare, there is an implication that quality can be objectively measured. In fact, the effectiveness of healthcare is extremely difficult to quantify, not only because of medical uncertainty, but because of intangible elements like "quality of life". This is likely to lead to systems that measure only what is easy to measure, such as length of life, average waiting times, or infection rates, and may reduce the importance within the system of treatment of chronic, but non-fatal, conditions, or of providing the best care for the terminally ill. Thus, it is possible for personal satisfaction with the system to go down, while metrics go up. SEE ALSO
EXTERNAL LINKS
|
|
|